Alert detail

LCD L37897: MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer — Noridian

Policy ID: LCD-L37897Specialty: OncologyAdded: 6/5/2026Effective: January 22, 2026lcd
Routine

What changed

New liquid biopsy tests for lung cancer impact billing.

Who’s affected: Oncology billing teams · Effective: January 22, 2026

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 7 billing codes.

The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.